MRS. CHERYL LYNN JACKSON, OTR/L
Occupational Therapy at Lorna Rd, Birmingham, AL

License number
Alabama 216
Category
Restorative Service Providers
Type
Occupational Therapist
Address
Address
3057 Lorna Rd STE 220, Birmingham, AL 35216
Phone
(205) 978-9939
(205) 968-4157 (Fax)

Personal information

See more information about CHERYL LYNN JACKSON at radaris.com
Name
Address
Phone
Cheryl Jackson, age 75
4618 Ardmore Dr NW, Huntsville, AL 35816
(256) 895-7268
Cheryl Jackson, age 52
4779 Fulmar Dr, Birmingham, AL 35210
(205) 835-1101
Cheryl Jackson
431 W Lafayette St, Marion, AL 36756
(334) 683-6375
Cheryl Jackson, age 67
422 Golden Crest Cir, Birmingham, AL 35209
(205) 879-4219

Professional information

Cheryl Jackson Photo 1

Cheryl Jackson - Birmingham, AL

Work:
Keeton, Inc. - RRC
Case Manager
The Bridge, Inc - Gadsden, AL
Program Manager - Mitchell Program
The Salvation Army - Birmingham, AL
Program Coordinator
The Salvation Army - Birmingham, AL
Assistant Program Coordinator
The Salvation Army - Birmingham, AL
Counselor / Direct Care Employee
Education:
University of Alabama Birmingham - Birmingham, AL
B.S. in Criminal Justice


Cheryl Jackson Photo 2

Consultant At Jsf Childcare Unlimited

Position:
CONSULTANT at JSF CHILDCARE UNLIMITED
Location:
Birmingham, Alabama Area
Industry:
Education Management
Work:
JSF CHILDCARE UNLIMITED - CONSULTANT


Cheryl Jackson Photo 3

Poliovirus Replicons Encoding Therapeutic Agents And Uses Thereof

US Patent:
6680169, Jan 20, 2004
Filed:
Apr 16, 2001
Appl. No.:
09/835141
Inventors:
Casey D. Morrow - Birmingham AL
Cheryl Jackson - Hoover AL
Jean Peduzzi - Clanton AL
Assignee:
University of Alabama Research Foundation - Birmingham AL
International Classification:
C12Q 100
US Classification:
435 5, 424 9321, 514 44
Abstract:
The invention pertains to methods of delivering a polypeptide to a cell comprising (a) contacting a cell with a replicon having a non-poliovirus nucleic acid substituted for a nucleic acid which encodes at least a portion of a protein necessary for encapsidation, the non-poliovirus nucleic acid encoding, in an expressible form, a polypeptide or fragment thereof; and (b) maintaining the cells under conditions appropriate for introduction of the replicons into the cells. The cell may be within a subject and the polypeptide may be a therapeutic agent. The methods of the invention may be used to treat diseases including central nervous system disorders, infectious diseases, and cancer.